Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.74 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | IAPP | P10997 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | BID | P55957 | 3/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.30 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.30 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10613392 | 0.96 | GABRA1 (0.81) | GABRA1GABRB2CYP3A4DAOTSHR | |
| SCHEMBL11732170 | 0.89 | GABRA1 (0.59) | GABRA1GABRB2CYP3A4DAO | |
| SCHEMBL8156690 | 0.89 | GABRA1 (0.59) | GABRA1GABRB2CYP3A4DAOTSHR | |
| SCHEMBL10614732 | 0.88 | GABRA1 (0.58) | GABRA1GABRB2CYP3A4DAO | |
| SCHEMBL10613242 | 0.88 | GABRA1 (0.58) | GABRA1GABRB2CYP3A4DAOTSHR | |
| SCHEMBL10613027 | 0.88 | GABRA1 (0.62) | GABRA1GABRB2CYP3A4DAOPPARG | |
| SCHEMBL9622722 | 0.85 | GABRA1 (0.65) | GABRA1GABRB2PPARGPPARABID | |
| SCHEMBL18258702 | 0.85 | GABRA1 (0.52) | GABRA1GABRB2DAOELANEIAPP | |
| SCHEMBL1457739 | 0.85 | GABRA1 (1.00) | GABRA1GABRB2CYP3A4DAOTSHR | |
| SCHEMBL28007487 | 0.85 | GABRA1 (0.54) | GABRA1GABRB2CYP3A4DAOTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12578664-B2 | Toner and method for producing toner | CANON KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12535750-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2026-01-27 | — | — | US | disclosed |
| US-12429789-B2 | Toner and method for producing toner | CANON KABUSHIKI KAISHA (JP) | 2025-09-30 | — | — | US | disclosed |
| US-12386278-B2 | Toner and method for producing toner | CANON KABUSHIKI KAISHA (JP) | 2025-08-12 | — | — | US | disclosed |
| US-12351542-B2 | Spacered urea (meth)acrylates | EVONIK OPERATIONS GMBH (DE) | 2025-07-08 | — | — | US | disclosed |
| US-12338202-B2 | One pot synthesis of urea (meth)acrylates | EVONIK OPERATIONS GMBH (DE) | 2025-06-24 | — | — | US | disclosed |
| US-12298709-B2 | Toner and method for producing toner | CANON KABUSHIKI KAISHA (JP) | 2025-05-13 | — | — | US | disclosed |
| CN-114637173-B | Toner and method for producing toner | 佳能株式会社 | 2025-01-24 | — | — | CN | disclosed |
| CN-110597029-B | Toner and method for producing toner | 佳能株式会社 | 2025-01-03 | — | — | CN | disclosed |
| CN-110597033-B | Toner and method for producing toner | 佳能株式会社 | 2024-12-27 | — | — | CN | disclosed |
| CN-110597031-A | Toner and image forming apparatus | 佳能株式会社 | 2019-12-20 | — | — | CN | disclosed |
| CN-110597033-A | Toner and method for producing toner | 佳能株式会社 | 2019-12-20 | — | — | CN | disclosed |
| CN-110597027-A | Toner and method for producing toner | 佳能株式会社 | 2019-12-20 | — | — | CN | disclosed |
| CN-110597030-A | Toner and two-component developer | 佳能株式会社 | 2019-12-20 | — | — | CN | disclosed |
| CN-110597028-A | Magnetic toner and method for producing magnetic toner | 佳能株式会社 | 2019-12-20 | — | — | CN | disclosed |
| CN-109952539-A | Toner binder for electrophotography and toner composition | 三洋化成工业株式会社 | 2019-06-28 | — | — | CN | disclosed |
| EP-1042278-B1 | 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF | SLOVAKOFARMA AS (SK) | 2003-03-05 | — | — | EP | disclosed |
| US-6444691-B1 | ANTICHOLESTEROL AGENTS | SOLVAKOFARMA, A.S. (SK) | 2002-09-03 | — | — | US | disclosed |
| EP-1042278-A1 | 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF | Slovakofarma, A.S. (SK) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999032437-A1 | 1,3-DISUBSTITUTED UREAS AS ACAT INHIBITORS, AND METHOD OF PREPARING THEREOF | SLOVAKOFARMA, A.S. (SK) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351542-B2 | Spacered urea (meth)acrylates | METTL14, METTL3, FUS | GABRA1 459/4885GABRB2 1101/4885CYP3A4 3343/4885 |
| US-12338202-B2 | One pot synthesis of urea (meth)acrylates | ADH1A, ADH1C, METTL14 | GABRA1 2645/4885GABRB2 3364/4885CYP3A4 460/4885 |
| US-12578664-B2 | Toner and method for producing toner | C1R, TECR, FCGR2A | GABRA1 126/4885GABRB2 561/4885CYP3A4 1449/4885 |
| US-12535750-B2 | Toner | TAS1R3, TAS2R3, TAS2R43 | GABRA1 258/4885GABRB2 984/4885CYP3A4 2842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.